News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ZenBio, Inc. Awarded $1.88 Million Phase II SBIR Grant for Mesothelial Cell Program


1/27/2009 10:36:44 AM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--ZenBio, Inc. announced that it has been awarded a Phase II SBIR grant to commercialize primary human peritoneal mesothelial cells. The $1.88 million award from the National Institutes of Health will fund continued optimization and commercial development of this unique tool for cancer, obesity, and type 2 diabetes research.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES